Aprea Therapeutics Cash from Operations (TTM) Trends

Aprea Therapeutics Inc (APRE)

5.50 +0.36 (+7.11%) USD | NASDAQ | May 09, 16:00

5.15 -0.35 (-6.36%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-12.18M
September 30, 2023	-12.46M
June 30, 2023	-16.81M
March 31, 2023	-22.49M
December 31, 2022	-25.01M
September 30, 2022	-31.17M
June 30, 2022	-32.81M
March 31, 2022	-31.66M
December 31, 2021	-37.69M

Date	Value
September 30, 2021	-40.71M
June 30, 2021	-43.90M
March 31, 2021	-45.78M
December 31, 2020	-41.80M
September 30, 2020	-43.35M
June 30, 2020	-34.72M
March 31, 2020	-30.05M
December 31, 2019	-26.71M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-45.78M

Minimum

Mar 2021

-12.18M

Maximum

Dec 2023

-31.13M

Average

-31.66M

Median

Mar 2022

Cash from Operations (TTM) Benchmarks